Vol. 35 (1987) Granules prepared are listed in Table I . Release Study Release of sodium dichlofenac was examined by the rotating basket method in JP X at 100 rpm or at 150 rpm.5) One gram of granules was employed for each study and 500 ml of JP X 2nd fluid (pH 6.8; 0.2 rvt KH2PO4-NaOH buffer) was used as the medium at 37°C. The basket was covered with cotton gauze. After starting the experiment, 1 ml aliquots were collected through a Millipore filter (pore size of 0.45 [em) at designated time intervals for 24 h. The concentration of sodium diclofenac in each sample solution was measured by spectrophotometric method at the wavelength of 275 nm, or by high-performance liquid chromatography.6) Statistical Analysis Statistical analyses were performed by using Student's t-test.
Results and Discussion
Granules of code-1 to code-4 with the same content of sodium diclofenac (50 mg/g) were examined, together with a commercial tablet containing 25 mg of sodium diclofenac. As shown in Fig. 1 , release of diclofenac from granules of code-1 was only slightly slower than that from the commercial tablet. A greater content of cholesterol in the granules caused a slower release of diclofenac. Thus, it is considered that cholesterol delays the degradation of granules, or decreases the volume of medium infiltration into the matrix or the rate of its infiltration.
Release of a drug from granules often occurs as a result of degradation of the granules, as suggested by Hixson and Crowell:7) In this case, drug release may be represented by Eq. 1 (the Hixson-Crowell eauation)2) (1) where Wo represents the total amount of drug in the granules, W, represents the remaining amount of drug in the granules after time t (remaining amount was calculated from the measurement of the released amount in the present study), and k, is a constant for each type of granules. As shown in Fig. 2A , data analyzed according to Eq. 1 did not give a good straight line, especially at the early stage, except for code-1. Thus, release of diclofenac seems to occur through the mechanism of granule degradation only from granules of code-1. Since degradation of granules of code-2, code-3 and code-4 was not apparent to the naked eye at least up to 8 h, another mechanism may be involved in the release of diclofenac from these granules. Further, it was observed that the initial release of diclofenac was greater than expected. This initial burst of release of diclofenac may reflect rapid dissolution of diclofenac which was adsorbed on the granule surface (see below).
A possible mechanism of the drug release from granules of code-2 to -4 may be leaching, as proposed by Higuchi.8 This is described by Eq. 2: (2) where Q represents the amount of drug released from unit surface area, D represents the diffusivity of the drug in the infiltration solvent, c represents the porosity of granules, represents the toutuosity factor of granules, A represents the total amount of drug in unit volume and Cs is the solubility of the drug in the infiltration medium (Cs of sodium diclofenac in the solvent was 18 mm at 37 °C). The fraction, F, of diclofenac released from test granules can be represented by Eq. 3: (3) where S represents the total surface area, V, represents the total volume of granules, and Q' represents the amount of diclofenac released from the granules tested. As shown in Fig. 2B , a plot of F against the square root of time (h) gave a good straight line for each of the granules. These results suggest that release of diclofenac from granules occurs by leaching. The slope, k2, of the line is represented by Eq. 4 (4) Since the solubility of sodium diclofenac is low, it may be estimated that 2A is greater 
In Eq. 5, the change of k2 is related to the value of O. Thus, the decrease of k2 value with the increase of cholesterol content in the granules may indicate that cholesterol decreases the value of EIT in Eq. 5. When the k2 values for granules of code-2 to -4 were plotted (closed circles in Fig. 3 ) against the square root of the content ratio of cholesterol, a good straight line was obtained. This result suggests that cholesterol in granules decreases the porosity of the granules and/or increases the tortuosity of the granules. Thus, release of sodium diclofenac from granules prepared with lecithin can be controlled easily by adjusting the cholesterol content.
Since sodium diclofenac dissolves in the infiltration medium, decrease of the content of sodium diclofenac may decrease the value of EIT in Eq. 5. To investigate the effect of content of sodium diclofenac, code-3, code-5, code-6 and code-7 granules were used. As shown in Table  II , a smaller content of sodium diclofenac in granules resulted in a smaller k2 value. However, since increase of the content of sodium diclofenac in the granules prepared in this study was accompanied with a decrease of cholesterol content, the k2 value was also plotted against the square root of the content ratio of cholesterol. In this case, the value of slope obtained from (Table  II) .
However, the release from code-1 granules at 150 rpm was greater than that at 100 rpm (Table   II) 
